TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/7/24 12:24 | 6/7/24 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Catelani Michael | CA | O | P,COO,CF | P | 15 | 2.40 | 0 | 6 | 22 | 35 | D | ||||||||||||||
7/21/23 10:06 | 7/20/23 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Catelani Michael | CA | O | P,COO,CF | P | 20 | 3.64 | 0 | 6 | 26 | 27 | D | ||||||||||||||
4/22/22 09:50 | 4/21/22 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Catelani Michael | CA | O | P | P | 15 | 2.66 | 0 | 6 | 44 | 18 | D | ||||||||||||||
4/21/22 11:28 | 4/20/22 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Catelani Michael | CA | O | P | P | 6 | 2.53 | 0 | 3 | 25 | 13 | D | ||||||||||||||
9/19/18 11:47 | 9/18/18 | ITUS | Itus Corp | DE | Health | Health | Medical Laboratories | Catelani Michael | CA | O | COO,CFO | P | 10 | 4.45 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |